Perkins Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-218
| Closed | -$25K | – | 112 |
|
|
2016
Q3 | $25K | Sell |
218
-96
| -31% | -$11K | 0.03% | 108 |
|
|
2016
Q2 | $30K | Sell |
314
-68
| -18% | -$6.5K | 0.03% | 110 |
|
|
2016
Q1 | $44K | Sell |
382
-76
| -17% | -$8.75K | 0.06% | 107 |
|
|
2015
Q4 | $77K | Sell |
458
-254
| -36% | -$42.7K | 0.08% | 111 |
|
|
2015
Q3 | $148K | Sell |
712
-192
| -21% | -$39.9K | 0.16% | 103 |
|
|
2015
Q2 | $446K | Sell |
904
-25
| -3% | -$12.3K | 0.39% | 77 |
|
|
2015
Q1 | $449K | Buy |
929
+708
| +320% | +$342K | 0.38% | 85 |
|
|
2014
Q4 | $126K | Sell |
221
-60
| -21% | -$34.2K | 0.11% | 118 |
|
|
2014
Q3 | $285K | Buy |
+281
| New | +$285K | 0.24% | 100 |
|